2023 MSK Cardio-Oncology Symposium

Thursday, May 11, 2023, 8:00 AM - Friday, May 12, 2023, 6:00 PM, Rockefeller Research Laboratories, 430 East 67th Street, New York, NY

The discovery of new cancer therapeutics has significantly improved cancer survival but often at the expense of exposure to treatment that have long term and short-term cardiovascular effects. These cardiovascular complications have major impact on mortality and mortality, at times exceeding that of the primary malignancy.

With cancer mortality decreasing, cardiovascular disease has emerged as a formidable competing cause of death. Cancer survivors now demonstrate 2-5 times higher risk of mortality due to cardiovascular disease than the general population, threatening to limit the gains achieved in cancer survival. In response to the growing concerns of the CV challenges faced by patients with cancer, the field of cardio-oncology has evolved, which consists of experts in both cancer and cardiology working to improve the detection, monitoring and treatment of CV disease at each stage of the cancer care continuum. The field is rapidly growing as it advances to meet the urgent need to improve the cardiovascular health of patients with cancer.

Join us in-person in New York City for this state-of-the-art, comprehensive, case-based curriculum that addresses important clinical topics relevant to the cardiovascular health of patients with cancer. Together, an interdisciplinary group, consisting of cardiology and oncology experts from Memorial Sloan Kettering Cancer Center and around the world, will present the latest research and contemporary practice strategies in prevention, early diagnosis, and management of cardiovascular disease in patients with cancer.

This meeting will provide a forum for networking and professional collaboration. All presentations will include devoted time for interaction between audience members and presenters. Additionally, a complimentary networking reception will be held on Thursday, May 11, 2023, following the meeting, to provide an opportunity for the cardio-oncology community to interact and get to know each other. Please RSVP for the networking reception during registration. We hope to see you there!

For additional details, view the course brochure and agenda.

Who Should Attend

This symposium is intended for cardiologists, internists, hematologists/oncologists and other affiliated healthcare professionals who are involved in the care of cancer patients or have an interest in the field of cardio-oncology.

1. Describe contemporary breast cancer treatment and best practices in cardiotoxicity monitoring and management.
2. Define the role of immunotherapy in cancer therapy and their associated cardiovascular effects.
3. Discuss conventional and modern cancer therapy for hematologic malignancies, the oncologic indications and their associated cardiotoxicities.
4. Explain the contemporary management of prostate cancer and the optimal cardioprotective strategy to optimize cardiovascular health.
5. State the diagnostic and treatment strategies for cardiac amyloidosis including advances in therapy.
6. Recognize the change in radiation therapy over time and identify best practices in monitoring and managing the cardiovascular side effects.
7. Apply evidence-based strategies for primary and secondary prevention of cardiotoxicity during and after therapy.
8. Recognize the appropriate use of imaging modalities for cardiotoxicity monitoring - which modality, how often and which patient?
9. State the late cardiovascular sequelae of cancer and its treatment and the best approach to manage the cardiovascular health of cancer survivors.
10. Illustrate the challenges of managing cardiovascular disease in cancer patients during and after cancer treatment.

Course registration includes continental breakfast, lunch, refreshment breaks, and an invitation to the networking reception on Thursday evening. Please contact [email protected] at least one week prior to the course if you have any special dietary requests or require any specific accommodations.

While MSK requests that institutional guests are vaccinated against COVID-19, we are no longer requiring proof of vaccination. Additional details, including our current Health and Safety Protocols, can be accessed on our Visiting Us page. If you are not feeling well or exhibiting any symptoms of COVID-19, please refrain from attending an in-person event at MSK and contact [email protected] as soon as possible.

Registration Fees

• Physicians (MDs, PhDs, and DOs)
  • Early Rate: $450
  • General Rate: $550
• Advanced Practice Providers 
  • Early Rate: $300
  • General Rate: $400
• Residents, Fellows, Nurses, and Other Healthcare Providers
  • Early Rate: $250
  • General Rate: $350
• Industry Professionals*
  • Early Rate: n/a
  • General Rate: $965
• MSK Employees
  • Complimentary

*Industry professionals may attend MSK CME activities for their own education. Marketing, sales, and promotion of products and services is strictly prohibited at MSK CME activities. For more information, please visit our Help page.

Registration Discounts/Promotions

• EARLY RATE: Receive $100 off the registration fee by entering promo code CARDIO523 during registration. Offer ends March 31, 2023. 
• A registration discount is available for MSK Alumni and MSK Cancer Alliance to attend. If you are a member of one of these groups, contact [email protected] for details.

Please note that after your payment has been processed, no further promotional discounts or adjustments will be made to your registration.

Cancellation Policy

If you wish to cancel your participation in this course, you must email [email protected] at least seven (7) days prior to the start of the course, and your refund will be subject to a $25 administrative fee. Cancellations or no-shows within seven (7) days of the course are not eligible for a refund. Please note that if it has been more than 120 days since payment was processed, a W9 form must be submitted in order process your refund and your refund will be issued in the form of a check payment. Refunds are not subject to tax. You may substitute another registrant in your place at any time by contacting [email protected] with the appropriate information.

MSK CME reserves the right to cancel or postpone any course due to unforeseen circumstances. In the unlikely event we must cancel or postpone this course, you will be notified via email from MSK CME ([email protected]). A full refund will be issued for your registration. MSK CME is not responsible for any related costs, charges, or expenses to participants, including fees incurred by airline/travel/lodging agencies.

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement

Memorial Sloan Kettering Cancer Center designates this live activity for a maximum of 16.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC Recognition Statement

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 16.75 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Symposium Director 

Jennifer Liu, MD
Chief, Cardiology Service
Memorial Sloan Kettering Cancer Center 

 

Symposium Co-Director

Richard M. Steingart, MD
Emeritus Member, Cardiology Service
Memorial Sloan Kettering Cancer Center 

 

Symposium Planning Committee 

Carol L. Chen, MD
Vice Chair, Quality Assurance
Attending, Cardiology Service
Memorial Sloan Kettering Cancer Center 

Debra E. Edwards
Patient Planner

Eileen Vella, PA-C
Advanced Practice Provider Manager
Memorial Sloan Kettering Cancer Center 

 

Invited Faculty 

Husam Abdel-Qadir, MD, PhD
Women’s College Hospital 
Toronto General Hospital
Toronto, Canada

Ana Barac, MD, PhD
Inova Heart and Vascular Institute
Falls Church, VA

Deepak Bhatt, MD, MPH
Mt. Sinai Health System
New York, NY

Susan Dent, MD
Duke University Medical Center
Durham, NC

Anita Deswal, MD, MPH
MD Anderson Cancer Center
Houston, TX

Stephanie Dixon, MD, MPH
St. Jude Children’s Research Hospital
Memphis, TN

Debra E. Edwards
New York, NY

Stephanie Feldman, MD
Rutgers New Jersey Medical School
Newark, NJ

Michael Fradley, MD
University of Pennsylvania
Philadelphia, PA

Sidney Glasofer, MD
Atlantic Medical Group
New Providence, NJ

Kristine Jang, DO
Stony Brook University Hospital
Stony Brook, NY 

Luke Kim, MD
Weill Cornell Medical College
New York, NY

Daniel Lenihan, MD
International Cardio-Oncology Society
Tampa, FL

Darryl Leong, MBBS, MPH, PhD
McMaster University
Ontario, Canada

Teresa Lopez-Fernandez, MD
La Paz University Hospital
Madrid, Spain

Syed Mahmood, MD, MPH
St. Francis Heart Center
Roslyn, NY

Mathew Maurer, MD
Columbia University Irving Medical Center
New York, NY

Tomas Neilan, MD, MPH
Massachusetts General Hospital
Boston, MA

Anju Nohria, MD, MSC 
Dana Farber Brigham Cancer Center
Boston, MA

Marielle Scherrer-Crosbie, MD, PhD
University of Pennsylvania
Philadelphia, PA

Jonathan Weinsaft, MD
Weill Cornell Medical College
New York, NY

 

MSK Faculty 

Lior Z. Braunstein, MD
Radiation Oncology 

Angel T. Chan, MD, PhD
Cardiology Service 

Chau T. Dang, MD
Breast Oncology Service 

Neisha DeJesus, DMSc, PA-C
Advance Practice Provider 

Megan Durkin, DMSc, PA-C
Advance Practice Provider 

Danielle N. Friedman, MD, MS 
Pediatrics 

Sergio A. Giralt, MD
Bone Marrow Transplant 

Dipti Gupta, MD, MPH
Cardiology Service 

Michelle N. Johnson, MD, MPH
Cardiology Service 

Ioanna Kosmidou, MD
Cardiology Service 

Andrew Laccetti, MD, MS
Genitourinary Oncology Service 

Heather J. Landau, MD
Bone Marrow Transplant 

Sarah Linhares, ACNP-BC, BSN, CHFN, DNP
Advance Practice Provider 

Michael A. Postow, MD
Melanoma Service

Wendy Schaffer, MD, PhD
Cardiology Service 

Deb Schrag, MD, MPH
Gastrointestinal Oncology Service 

Jessica Scott, PhD
Exercise Oncology Service 

Anthony F. Yu, MD, MS
Cardiology Service

Jeffrey Zwicker, MD
Hematology Service

Mitigation of Relevant Financial Relationships

Memorial Sloan Kettering Cancer Center adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers, or others are required to disclose all financial relationships with ineligible companies (commercial interests). All relevant financial relationships have been mitigated prior to the commencement of the activity.